Hydrocephalus Panel
Use
This test is designed for individuals with clinical or suspected diagnosis of hydrocephalus, those with prenatal-onset or early-childhood presentations of hydrocephalus, and those with hydrocephalus with or without other genetic anomalies. It aims to assist in diagnosing hydrocephalus and to determine genetic underpinnings that could influence patient management or therapeutic decisions.
Special Instructions
Not provided.
Limitations
The test cannot detect genetic conditions not covered by the included 38 genes. It requires specific specimen types which must be collected and stored as per the guidelines provided. Results are contingent on the integrity of the specimen and the clinical information provided. The test is not FDA approved, and performance characteristics were validated by PreventionGenetics LLC under CAP and CLIA regulations.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided